Cargando…

Long-term galsulfase enzyme replacement therapy in Taiwanese mucopolysaccharidosis VI patients: A case series

BACKGROUND: Information regarding the long-term outcome of enzyme replacement therapy (ERT) with recombinant human N-acetylgalactosamine 4-sulfatase (rhASB, galsulfase, Naglazyme®, BioMarin Pharmaceutical Inc.) for Taiwanese patients with mucopolysaccharidosis (MPS) VI is limited. METHODS: Nine Taiw...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Hsiang-Yu, Chuang, Chih-Kuang, Wang, Chung-Hsing, Chien, Yin-Hsiu, Wang, Yu-Mei, Tsai, Fuu-Jen, Chou, Yen-Yin, Lin, Shio Jean, Pan, Hui-Ping, Niu, Dau-Ming, Hwu, Wuh-Liang, Ke, Yu-Yuan, Lin, Shuan-Pei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834679/ https://www.ncbi.nlm.nih.gov/pubmed/27134829 http://dx.doi.org/10.1016/j.ymgmr.2016.04.003

Ejemplares similares

Clinical characteristics and surgical history of Taiwanese patients with mucopolysaccharidosis type II: data from the hunter outcome survey (HOS)
por: Lin, Hsiang-Yu, et al.
Publicado: (2018)

Natural history and clinical assessment of Taiwanese patients with mucopolysaccharidosis IVA
por: Lin, Hsiang-Yu, et al.
Publicado: (2014)

Galsulfase (Naglazyme®) therapy in infants with mucopolysaccharidosis VI
por: Harmatz, Paul R., et al.
Publicado: (2013)

Causes of death and clinical characteristics of 34 patients with Mucopolysaccharidosis II in Taiwan from 1995–2012
por: Lin, Hsiang-Yu, et al.
Publicado: (2016)

Mucopolysaccharidosis type VI phenotypes-genotypes and antibody response to galsulfase
por: Brands, Marion M, et al.
Publicado: (2013)

Cardiac features and effects of enzyme replacement therapy in Taiwanese patients with Mucopolysaccharidosis IVA
por: Lin, Hsiang-Yu, et al.
Publicado: (2018)

Relationships among Height, Weight, Body Mass Index, and Age in Taiwanese Children with Different Types of Mucopolysaccharidoses
por: Lin, Hsiang-Yu, et al.
Publicado: (2019)

Cardiac characteristics and natural progression in Taiwanese patients with mucopolysaccharidosis III
por: Lin, Hsiang-Yu, et al.
Publicado: (2019)

Enzyme replacement therapy for mucopolysaccharidosis VI: long-term cardiac effects of galsulfase (Naglazyme(®)) therapy
por: Braunlin, E., et al.
Publicado: (2012)

Survival and diagnostic age of 175 Taiwanese patients with mucopolysaccharidoses (1985–2019)
por: Lin, Hsiang-Yu, et al.
Publicado: (2020)

Natural progression of cardiac features and long-term effects of enzyme replacement therapy in Taiwanese patients with mucopolysaccharidosis II
por: Lin, Hsiang-Yu, et al.
Publicado: (2021)

Mutant EXT1 in Taiwanese Patients with Multiple Hereditary Exostoses
por: Lin, Wei-De, et al.
Publicado: (2014)

A systematic review of new advances in the management of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): focus on galsulfase
por: El Dib, Regina P, et al.
Publicado: (2009)

Ophthalmologic manifestations in Taiwanese patients with mucopolysaccharidoses
por: Lin, Hsiang‐Yu, et al.
Publicado: (2019)

Functional independence of Taiwanese patients with mucopolysaccharidoses
por: Lee, Chung‐Lin, et al.
Publicado: (2019)

Reversed papilledema in an MPS VI patient with galsulfase (Naglazyme(®)) therapy
por: Koseoglu, Selim T., et al.
Publicado: (2008)

Identification and Functional Characterization of IDS Gene Mutations Underlying Taiwanese Hunter Syndrome (Mucopolysaccharidosis Type II)
por: Lin, Hsiang-Yu, et al.
Publicado: (2019)

Genotype and phenotype analysis of Taiwanese patients with osteogenesis imperfecta
por: Lin, Hsiang-Yu, et al.
Publicado: (2015)

Heterogeneous nonataxic phenotypes of spinocerebellar ataxia in a Taiwanese population
por: Chen, Szu‐Ju, et al.
Publicado: (2019)

Aortic Root Dilatation in Taiwanese Patients with Mucopolysaccharidoses and the Long-Term Effects of Enzyme Replacement Therapy
por: Lin, Hsiang-Yu, et al.
Publicado: (2020)

Clinical ocular manifestations of Taiwanese patients with mucopolysaccharidoses VI (Maroteaux–Lamy syndrome)
por: Lin, Hsu-Ying, et al.
Publicado: (2019)

Case report of Chromosome 3q25 deletion syndrome or Mucopolysaccharidosis IIIB
por: Chang, Yu-Tzu, et al.
Publicado: (2014)

RUNX2 mutations in Taiwanese patients with cleidocranial dysplasia
por: Lin, Wei-De, et al.
Publicado: (2011)

Endoscopic and Image Analysis of the Airway in Patients with Mucopolysaccharidosis Type IVA
por: Lee, Yi-Hao, et al.
Publicado: (2023)

Frequency and spectrum of actionable pathogenic secondary findings in Taiwanese exomes
por: Kuo, Chieh‐Wen, et al.
Publicado: (2020)

Bio-Plex immunoassay measuring the quantity of lysosomal N-acetylgalactosamine-6-sulfatase protein in dried blood spots for the screening of mucopolysaccharidosis IVA in newborn: a pilot study
por: Chuang, Chih-Kuang, et al.
Publicado: (2017)

Functional Independence of Taiwanese Children with Osteogenesis Imperfecta
por: Syu, Yu-Min, et al.
Publicado: (2022)

Normalization of glycosaminoglycan-derived disaccharides detected by tandem mass spectrometry assay for the diagnosis of mucopolysaccharidosis
por: Lin, Hsiang-Yu, et al.
Publicado: (2019)

Phenotype and genotype in a Taiwanese girl with Sotos Syndrome
por: Lin, Wei-De, et al.
Publicado: (2022)

A pilot newborn screening program for Mucopolysaccharidosis type I in Taiwan
por: Lin, Shuan-Pei, et al.
Publicado: (2013)

Quantification of Idua Enzymatic Activity Combined with Observation of Phenotypic Change in Zebrafish Embryos Provide a Preliminary Assessment of Mutated idua Correlated with Mucopolysaccharidosis Type I
por: Lin, Cheng-Yung, et al.
Publicado: (2022)

Endocrine and Growth Disorders in Taiwanese Children With 22q11.2 Deletion Syndrome
por: Lin, Han-Yi, et al.
Publicado: (2022)

Safety and efficacy of eliglustat combined to enzyme replacement therapy for lymphadenopathy in patients with Gaucher disease type 3
por: Lee, Ni-Chung, et al.
Publicado: (2022)

Cardiac Evaluation Using Two-Dimensional Speckle-Tracking Echocardiography and Conventional Echocardiography in Taiwanese Patients with Mucopolysaccharidoses
por: Lin, Hsiang-Yu, et al.
Publicado: (2020)

Mucopolysaccharidosis VI
por: Valayannopoulos, Vassili, et al.
Publicado: (2010)

Effect of Mutated ids Overexpression on IDS Enzyme Activity and Developmental Phenotypes in Zebrafish Embryos: A Valuable Index for Assessing Critical Point-Mutations Associated with Mucopolysaccharidosis Type II Occurrence in Humans
por: Lin, Cheng-Yung, et al.
Publicado: (2020)

Quantitative DNA Methylation Analysis and Epigenotype-Phenotype Correlations in Taiwanese Patients with Beckwith-Wiedemann Syndrome
por: Lin, Hsiang-Yu, et al.
Publicado: (2021)

Efficacy of Intravenous Elosulfase Alfa for Mucopolysaccharidosis Type IVA: A Systematic Review and Meta-Analysis
por: Lee, Chung-Lin, et al.
Publicado: (2022)

Otorhinolaryngological Management in Taiwanese Patients with Mucopolysaccharidoses
por: Lee, Chung-Lin, et al.
Publicado: (2021)

Rapid Weight Loss and Severe Failure to Thrive Mimicking Lipodystrophy Syndrome in a 1-Year-Old Taiwanese Girl with Costello Syndrome
por: Syu, Yu-Min, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1cmkde9j08bvcosaf5fo2ger6h